![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Novartis’ Cushing’s Disease Drug
FDA Approves Novartis’ Cushing’s Disease Drug
![Novartis building](https://www.fdanews.com/ext/resources/test/Drug-Images/Novartis-buliding.gif?t=1614205171&width=430)
The FDA approved Novartis’ Isturisa (osilodrostat) for treatment of adults with Cushing’s disease who cannot undergo surgery or who still have the disease following surgery.
Cushing’s disease is a rare condition that can lead to excessive production of cortisol, a steroid hormone that controls a variety of processes in the body.
Isturisa is the first drug approved by the agency to directly address cortisol overproduction by blocking the 11-beta-hydroxylase enzyme.
Upcoming Events
-
21Oct